ProfessionalLive ClassesNo New Dates

Integrating Psychedelics with Evidence-Based Therapy

Integrating Psychedelics with Evidence-Based Therapy is a 12-week reading and study group for individuals interested in evidence-based therapy and its application in psychedelic therapy. The course is designed for clinicians, graduate students, researchers, or the public who have a background in the

Provider

Fluence

English

Schedule

12 Weeks

Enrollment

$1,200

Decision Summary

Best fit
Professional learners
Format
Live Classes
Time commitment
12 Weeks
Credential signal
CE

Course Overview

Integrating Psychedelics with Evidence-Based Therapy is a 12-week reading and study group for individuals interested in evidence-based therapy and its application in psychedelic therapy. The course is designed for clinicians, graduate students, researchers, or the public who have a background in the scientific understanding of clinical interventions.

The course includes weekly discussion groups based on assigned readings that primarily come from academic literature. Topics will range from various evidenced-based therapies such as ACT, MI, CBT, and DBT to psychedelics like psilocybin, ketamine, and MDMA and their application in various clinical populations.

The course also critiques the current state of psychedelic therapy research and its ethical concerns. By the end of the course, participants will have a comprehensive understanding of the history, basic components, safety concerns, and pharmacology of psychedelic therapy, as well as the role of psychotherapy in psychedelic treatment.

This course runs multiple times per year.

About the Provider

Fluence is a psychedelic therapy education company co-founded by psychologists Dr. Ingmar Gorman and Dr. Elizabeth Nielson, offering continuing education courses and a Certificate in Psychedelic Therapy and Integration for licensed therapists and advanced graduate students. Having trained 8,000+ clinicians, Fluence draws on its founders' direct experience in FDA-approved Phase 3 clinical trials of MDMA- and psilocybin-assisted therapies.

Course FAQ

Who is this course for?

This listing is marked as Professional course in Ketamine Therapy, MDMA Therapy, Psilocybin Therapy, Integration, Clinical & Medical, Research & Science. Check the provider page for final admission or eligibility details.

What is the format and time commitment?

Format: Live Classes. Time commitment: 12 Weeks.

How much does it cost?

The listed price is $1,200. Confirm the latest tuition, fees, and payment options with [object Object].

Does it offer a certificate or CE/CME credit?

Accreditation note: CE. Confirm credential eligibility directly with the provider before enrolling.

Is this course currently available?

The current listing status is No New Dates. The course website was not reachable in the latest check, so use the provider or similar-course links as a backup.

Related Courses

View all courses
ActiveCertificateScholarship

Certificate in Psychedelic-Assisted Therapies and Research

By CIIS

Same course category

The Psychedelic-Assisted Therapies and Research Certificate Program at the California Institute for Integral Studies (CIIS) Center for Psychedelic Therapies and Research (CPTR) is designed to meet the growing need for the training of skilled therapists and researchers in the field of psychedelic-ass

Next cohort: Jun 1, 2026

Source lists: Estimated 145 hours

Delivery: San Francisco, United States + Online + Portland, United States

150 hours
Professional
$8,300
No New Dates

Pós-Graduação Em Psicotereapia Assistida Por Psicodélicos

By Instituto Alma Viva

Same course category

Explore the first MEC-approved Postgraduate Course in Psychedelic-Assisted Psychotherapy in Brazil, designed for psychologists and psychiatrists. Learn cutting-edge therapeutic techniques, gain practical experience, and contribute to pioneering research.

Source lists: 360 hours

Delivery: Online + São Paulo, Brazil

No medicine self-experience listed

18 months
Professional
$2,490